#AutoimmuneAwarenessMonth underscores our mission to support people living with #rheumatic diseases. Through increased research and development of #CellTherapies, we are working to build a future with safer, more accessible treatment options and relief for patients who are impacted by these diseases.?
Nkarta, Inc.
生物技术研究
South San Francisco，California 12,473 位关注者
Harnessing the Power of Natural Killer Cells
关于我们
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.
- 网站
-
https://www.nkartatx.com
Nkarta, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- South San Francisco，California
- 类型
- 上市公司
- 创立
- 2015
- 领域
- Cell Therapy、Immuno-Oncology和Autoimmune Disease
地点
-
主要
获取路线
1150 Veterans Blvd.
US，California，South San Francisco，94080
Nkarta, Inc.员工
动态
-
International Women’s Day (#IWD2025) recognizes the incredible women whose impactful contributions inspire us each day. Recently, we were honored to host Robin Toft, who shared her insights in a presentation titled, "Authenticity and developing skills around how to be one's best self and advance in all areas of life." Thank you to Robin for your inspiring presentation and thank you to the women at Nkarta for all that you do to make #NKcell therapy accessible to people who need it!?
-
-
-
-
-
+1
-
-
Our own Loan Hoang, Sr. Director of Quality Assurance, will be speaking at the upcoming ISPE San Francisco | Bay Area Chapter's 5th Annual Women in Biotech Frontiers event. This event celebrates the contributions of women in #biotech.?
Join us for the ISPE San Francisco | Bay Area Chapter's 5th annual Women in Biotech Frontiers event on March 7th, 2025, as we celebrate Women in Pharma: Honoring Their Trailblazing Contributions and Ongoing Impact! Register here: https://lnkd.in/dds2yGau Don’t miss this opportunity to be inspired and engage with leaders in the biotech industry. This unique event, in honor of International Women’s Day and Women’s History Month, highlights the groundbreaking technical contributions of women in emerging biotech fields. Enjoy a morning of informative presentations, followed by a networking lunch where you can connect with fellow professionals and our distinguished speakers. Check out our next speaker highlight! Speakers include: Taylor Chartier, CEO at Modicus Prime Loan Hoang, Sr. Director of Quality Assurance at Nkarta, Inc. Alina Arzamassky Biophysics PhD Candidate, Shoichet Lab, UCSF Product Manager, Deep Origin Event Details: Date: Friday, March 7, 2025 Time: 9:30 AM - 1:30 PM Venue: The Lighthouse, 685 Gateway Boulevard, South San Francisco, CA 94080 Pricing: ISPE Members: $80, Non-ISPE Members: $100 Event Sponsorships: Food Sponsor $1,000, Space Sponsor: $500 Seats are limited, so register today to secure your spot:https://lnkd.in/dds2yGau #ISPE #ISPESFBayArea #BiotechNetworking #PharmaNetworking #FutureOfPharma #PharmaProfessionals #TechInPharma #WomenInPharma #PharmaceuticalIndustry #WomenInSTEM #PharmaLeadership #STEMWomen #WomenInTech
-
We recently announced that?enrollment is open in our Ntrust-2 clinical trial for NKX019, an NK-cell therapy candidate engineered to deplete CD19-positive cells in B-cell mediated disease. Our mission is to provide patients in this area of unmet need in #autoimmune disease with more treatment options.?
-
-
This International Day of Women and Girls in Science, we’re celebrating the incredible #womeninstem at Nkarta, who are pushing the boundaries of science and making an impact in NK cell therapy development. Thank you for your dedication and inspiring work!???
-
-
In case you missed it, our President?Nadir Mahmood, Ph.D., recently joined industry leaders at #FierceJPMWeek 2025 in a panel discussing the evolving landscape of #celltherapy. Read more about?Dr. Mahmood's insights on CAR NK cell therapies for autoimmune diseases and Nkarta's patient-centric approach.?
-
-
February marks #BlackHistoryMonth and celebrates the tremendous achievements and contributions of the Black community throughout history. We are grateful for those who have paved an innovative path forward and helped to make the future brighter.?
-
We are building a pipeline of future cell therapies through our ongoing research and clinical trial initiatives focused on #autoimmune disease, Ntrust1 and Ntrust2. Our goal is to provide patients in this area of unmet need with more treatment options. Read more: https://lnkd.in/etkAqz-F??
Nkarta’s clinical trial options in autoimmune disease
-
By harnessing the body’s #NKcells – the immune system’s first responders – we aim to explore a safer, more tolerable and accessible treatment option to people living with #autoimmune diseases. Learn more about our clinical trial offerings: https://lnkd.in/etkAqz-F??
Pursuing safe, accessible NK cell therapies for autoimmune disease
-
We are pleased to share that our President, Nadir Mahmood, Ph.D., is participating in a panel at Fierce Life Sciences Events #FierceJPMWeek 2025. This event addresses the latest updates in #celltherapy, the centerpiece of our patient-first approach. Dr. Mahmood and fellow industry leaders will share insights on navigating regulatory hurdles, optimizing manufacturing, and leveraging emerging technologies to address additional disease states. Learn more: https://lnkd.in/dNCikKRB??
-